These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3934126)

  • 61. Vancomycin toxicity: a prospective study.
    Mellor JA; Kingdom J; Cafferkey M; Keane CT
    J Antimicrob Chemother; 1985 Jun; 15(6):773-80. PubMed ID: 4030539
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
    Farber BF; Moellering RC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):138-41. PubMed ID: 6219616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is vancomycin ototoxicity a significant risk?
    Shields RK; Martello JL; Potoski BA
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4572; author reply 4572-3. PubMed ID: 19770289
    [No Abstract]   [Full Text] [Related]  

  • 64. Monitoring vancomycin therapy.
    Rybak MJ; Boike SC
    Drug Intell Clin Pharm; 1986 Oct; 20(10):757-61. PubMed ID: 3769763
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vancomycin: a rapid HPLC assay for a potent antibiotic.
    Hoagland RJ; Sherwin JE; Phillips JM
    J Anal Toxicol; 1984; 8(2):75-7. PubMed ID: 6716979
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adverse effects of vancomycin administered in the perioperative period.
    Southorn PA; Plevak DJ; Wright AJ; Wilson WR
    Mayo Clin Proc; 1986 Sep; 61(9):721-4. PubMed ID: 3747614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vancomycin-induced ototoxicity in very-low-birthweight infants.
    Marissen J; Fortmann I; Humberg A; Rausch TK; Simon A; Stein A; Schaible T; Eichhorn J; Wintgens J; Roll C; Heitmann F; Herting E; Göpel W; Härtel C
    J Antimicrob Chemother; 2020 Aug; 75(8):2291-2298. PubMed ID: 32464660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nephrotoxicity with combination vancomycin-aminoglycoside therapy.
    Timpe EM
    J Pediatr Pharmacol Ther; 2005 Jul; 10(3):174-82. PubMed ID: 23118636
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vancomycin and nephrotoxicity.
    Gudmundsson GH; Jensen LJ
    Lancet; 1989 Mar; 1(8638):625. PubMed ID: 2564157
    [No Abstract]   [Full Text] [Related]  

  • 70. Vancomycin- and erythromycin-induced hearing loss in humans.
    Brummett RE; Fox KE
    Antimicrob Agents Chemother; 1989 Jun; 33(6):791-6. PubMed ID: 2669623
    [No Abstract]   [Full Text] [Related]  

  • 71. Prospective evaluation of red man syndrome in patients receiving vancomycin.
    O'Sullivan TL; Ruffing MJ; Lamp KC; Warbasse LH; Rybak MJ
    J Infect Dis; 1993 Sep; 168(3):773-6. PubMed ID: 8354921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse reactions to vancomycin.
    Schifter S; Aagaard MT; Jensen LJ
    Lancet; 1985 Aug; 2(8453):499. PubMed ID: 2863515
    [No Abstract]   [Full Text] [Related]  

  • 73. Vancomycin and chronic hypotension.
    Mellor J
    J R Soc Med; 1983 Jan; 76(1):83. PubMed ID: 6827506
    [No Abstract]   [Full Text] [Related]  

  • 74. Rigors with vancomycin.
    Conley NS; Weiner RS; Hiemenz JW
    Ann Intern Med; 1991 Aug; 115(4):330. PubMed ID: 1854124
    [No Abstract]   [Full Text] [Related]  

  • 75. Vancomycin-associated lacrimation.
    Temperley D; Casey E; Connolly R; FitzSimon S; Mulvihull E; Feely J
    Lancet; 1987 Dec; 2(8571):1337. PubMed ID: 2890939
    [No Abstract]   [Full Text] [Related]  

  • 76. Emergence of Rapid-Onset Ototoxicity Following Three Doses of Vancomycin: A Unique Case Report in the Context of Normal Renal Function and Therapeutic Dosing.
    Grabie YY; Chain S; Xerras M; Hong K; Khan SA
    Cureus; 2023 Nov; 15(11):e48647. PubMed ID: 38090406
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies.
    França A
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Compartmentalized Polymeric Nanoparticles Deliver Vancomycin in a pH-Responsive Manner.
    Ural MS; Menéndez-Miranda M; Salzano G; Mathurin J; Aybeke EN; Deniset-Besseau A; Dazzi A; Porcino M; Martineau-Corcos C; Gref R
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959274
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intra-wound vancomycin powder for the eradication of periprosthetic joint infection after debridement and implant exchange: experimental study in a rat model.
    Wei J; Tong K; Zhou S; Wang H; Wen Y; Chen L
    BMC Microbiol; 2021 Dec; 21(1):333. PubMed ID: 34876010
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Local Application of Vancomycin in One-Stage Revision of Prosthetic Joint Infection Caused by Methicillin-Resistant Staphylococcus aureus.
    Wei J; Wen Y; Tong K; Wang H; Chen L
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0030321. PubMed ID: 34181479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.